Ultragenyx Pharmaceuticals Appoints Eric Yuen, MD as Chief Medical Officer and Senior Vice President

Published: May 01, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

NOVATO, Calif., May 1, 2013 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc., a biotechnology company focused on the development of treatments for rare and ultra-rare genetic disorders, today announced it has appointed Eric Yuen, MD as its Chief Medical Officer and Senior Vice President. In this new role, Dr. Yuen will provide leadership and direction to Clinical Operations, Clinical Affairs, Clinical Sciences, Data Management/Biometrics, and Drug Safety. He will report to Dr. Emil Kakkis, CEO, and will serve on the Senior Management Team.

Help employers find you! Check out all the jobs and post your resume.

Back to news